DXC Technology Co (DXC)
Official siteTECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NYSE
Market Cap: $2.29B
Last updated: Nov 17, 2026 at 11:05 AM ET
DXC Technology Co (DXC) Stock Forecast
Analysts expect DXC Technology (DXC) to earn $2.37 per share in the fiscal year ending Mar 31, 2027, on revenue of $11.94B. Of 8 analysts, 0 rate the stock Buy or Strong Buy, 7 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Mar 31, 2027 were revised up and 6 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 3.25, inside the Hold band from 2.5 up to 3.5. Sell and Strong Sell make up 13% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 7 | 87.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 12.5% |
- Consensus
- Hold
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 13.5% and revenue estimates fall 2.8%.
- Fiscal year ending Mar 31, 2027
- $2.37
- EPS consensus, revenue $11.94B
- Fiscal year ending Mar 31, 2028
- $2.69
- EPS consensus, revenue $11.60B
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | $2.37 | $2.31 to $2.41 | 7 | $11.94B | $11.93B to $11.96B | 7 |
| Mar 31, 2028 | $2.69 | $2.41 to $3.23 | 7 | $11.60B | $11.40B to $12.06B | 7 |
Quarterly Estimates
The EPS consensus rises from $0.56 for the quarter ending Dec 31, 2026 to $0.75 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.56 | $0.55 to $0.57 | 7 | $2.97B | $2.97B to $2.98B | 5 |
| Mar 31, 2027 | $0.75 | $0.69 to $0.83 | 10 | $2.97B | $2.87B to $3.10B | 8 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 18 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Mar 31, 2027 | 0 | 6 |
| Fiscal year ending Mar 31, 2028 | 0 | 6 |
| Quarter ending Dec 31, 2026 | 0 | 6 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has fallen 8.1% from $2.58.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Mar 31, 2027 | $2.37 | $2.56 | $2.59 | $2.59 | $2.58 | -8.2% |
| Fiscal year ending Mar 31, 2028 | $2.69 | $2.92 | $2.96 | $2.96 | $2.99 | -10.0% |
| Quarter ending Dec 31, 2026 | $0.56 | $0.79 | $0.81 | $0.81 | $0.80 | -30.7% |
Frequently Asked Questions About DXC
What is the DXC stock forecast?
Consensus analyst estimates put DXC Technology's EPS at $2.37 for the fiscal year ending Mar 31, 2027, on revenue of $11.94B. The consensus rating from 8 analysts is Hold.
How do analysts rate DXC stock?
Of 8 analysts covering DXC Technology, 0 rate it Strong Buy, 0 Buy, 7 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from DXC next year?
For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $2.37, with estimates from $2.31 to $2.41 from 7 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $2.69, with estimates from $2.41 to $3.23 from 7 analysts.
What revenue do analysts expect from DXC Technology next year?
For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $11.94B, with estimates from $11.93B to $11.96B. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $11.60B, with estimates from $11.40B to $12.06B.
How many analysts cover DXC?
8 analysts rate DXC Technology stock, and 7 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.
DXC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts